TrialPloS one2015

Ozanezumab dose selection for amyotrophic lateral sclerosis by pharmacokinetic-pharmacodynamic modelling of immunohistochemistry data from patient muscle biopsies.

Alienor Berges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.